Incident Log Propionibacterium 047 A
All Staff Advisory: This is a report of an incident in progress. Please refer to Memorandum 047-0191 if you have been assigned to this incident or are otherwise associated with SCP-047.

Coordinating Agent's Summary: On 30/01/2010, storage locker 047c (Site-██ lab 047b), containing bacterial samples mutated by SCP-047, was compromised. Three (3) samples, of a total twelve (12), were stolen. Once per month since the initial containment break, outbreaks of one of the stolen bacterial strains, Propionibacterium 047-A, have been recorded globally. Further information on stolen material, spread, and containment follows.

Incident Handling Objectives:

  1. Re-acquire the stolen samples and ensure that no further copies exist outside of Foundation hands,
  2. Quarantine all infected civilians and stop the spread of P-047-A and any further strains which may be released,
  3. Determine the motivation behind the attack.

Description of Compromised Items

D-15978 infected with P-047-A, 2 days after initial exposure.

Propionibacterium 047-A is a strain of P. acnes mutated by SCP-047.

  • Pathogenicity: Severe skin colonisation around sebaceous glands. Modification of skin pH to levels that become toxic to skin cells. Massive inflammation and immune cell infiltration. Eventual breakdown of skin structure leading to sepsis.
  • Transmission: Transmitted by skin-to-skin contact. Can remain active on inorganic surfaces for up to five hours.
  • Lethality: Approximately 40% mortality rate. Runs its course in 2-6 weeks. Very visible symptoms within 5-10 hours; contagious within 2-5 hours.
  • Handling: As soon as visible symptoms form, victims must be quarantined. Deceased victims should be incinerated.

Streptococcus 047-C is a strain of S. mitis mutated by SCP-047.

  • Pathogenicity: Causes inflammation of the mouth and esophagus initially. Leads to open sores in the mouth, which result in S-047-C entering the bloodstream and becoming septic. Death is usually due to infective endocarditis.
  • Transmission: Somewhat aerosol; not transmitted in breath, but occasionally by coughing and spitting. Can remain active indefinitely by sporulation.
  • Lethality: Approximately 35% mortality rate. May become a recurring chronic condition if nonlethal.
  • Handling: Subjects with any sign of mouth infection should be quarantined. Deceased victims should be incinerated.

Clostridium 047-A is a strain of C. difficile mutated by SCP-047.

  • Pathogenicity: Unknown. C-047-A was developed from tissue culture and has never been exposed to a human. No samples remain in Foundation control.
  • Transmission: Unknown. Presumably transmitted through fecal contamination, as with C. difficile. Due to smaller, more robust spores, may also aerosolise with flatus. Effects of aerosol intake of C-047-A cannot be predicted.
  • Lethality: Unknown. Presumed extremely high risk of destruction of endothelial lining of gastrointestinal tract, leading to inflammation, sepsis, toxic megacolon.
  • Handling: Until further research has been done, victims should be quarantined and placed under 24 hour medical observation to develop functional diagnostics for this strain.

Outbreak information:
Note: Date listed is calculated date of initial "patient zero" infection on site, ±1 day.
First Outbreak: P-047-A, 27/02/2010, Siberia. Contained: see Incident Report P047A-03-2010.
Second Outbreak: P-047-A, 30/03/2010, Northwest Territories (Canada). Contained: see Incident Report P047A-04-2010
Third Outbreak: P-047-A, 29/04/2010, South Australia. Contained: see Incident Report P047A-05-2010
Fourth Outbreak: P-047-A, 27/05/2010, Mato Grosso (Brazil). Believed contained: see Incident Report P047A-06-2010. Warning: Agents in the area are advised to familiarise themselves with the symptoms of P-047-A and be on the lookout for possible infection.
Fifth Outbreak: P-047-A, 26/06/2010,
Sixth Outbreak: P-047-A, 26/07/2010,
Seventh Outbreak: P-047-A, 24/08/2010,
Eighth Outbreak: P-047-A, 23/09/2010,
Ninth Outbreak: P-047-A, 23/10/2010,

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License